PDCD1LG2 and neoplasm: Most studies on immunosuppressive molecules, such as Siglec-15, PD-L1, and PD-L2, have concentrated mainly on immune cells or the interaction between immune cells and tumor cells in the tumor microenvironment (TME) [30–34].